GGrantIndex
← Leaderboards

A. Darise Farris

Oklahoma Medical Research Foundation

$16,682,449
Attributed
$21,056,399
Total exposure
16
Grants
12
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.3M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$25,501,692 · 17

By mechanism

U19$10,616,740 · 8
UC2$5,801,518 · 1
R01$5,748,480 · 3
P50$1,925,867 · 2
R21$925,246 · 2
K02$483,841 · 1

Top collaborators

Most similar at Oklahoma Medical Research Foundation

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsMolecularLeadPhenotypeSiteMediatingAutoantigensTissuesCell TypeInfectionImmunologicsS SyndromeAutoimmunityImmuneSjogren&AposT-LymphocyteAntigensProductionB-LymphocytesAutoimmune DiseasesPathway InteractionsDesignInflammationAnthrax Disease

Grant awards (56)

Sjögren’s Team for Accelerating Medicines Partnership (STAMP)$1,749,759
UC2 · FY2025 · DE
Sjögren’s Team for Accelerating Medicines Partnership (STAMP)$951,759
UC2 · FY2024 · DE
Sjögren’s Team for Accelerating Medicines Partnership (STAMP)$600,000
UC2 · FY2024 · DE
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax$2,221,316
U19 · FY2023 · AI · contact PI
Sjögren’s Team for Accelerating Medicines Partnership (STAMP)$1,600,000
UC2 · FY2023 · DE
Immune cell mechanisms of Bacillus anthracis sepsis$496,661
U19 · FY2023 · AI · contact PI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax$2,223,977
U19 · FY2022 · AI · contact PI
Sjögren’s Team for Accelerating Medicines Partnership (STAMP)$900,000
UC2 · FY2022 · DE
Specificity and Molecular Definition of Pathogenic Lymphocytes in Sjogren's Syndrome$520,558
R01 · FY2022 · AR · contact PI
Immune cell mechanisms of Bacillus anthracis sepsis$460,617
U19 · FY2022 · AI · contact PI
Administrative Core$134,540
U19 · FY2022 · AI · contact PI
Core-001$83,904
U19 · FY2022 · AI · contact PI
Specificity and Molecular Definition of Pathogenic Lymphocytes in Sjogren's Syndrome$521,813
R01 · FY2021 · AR · contact PI
Immune cell mechanisms of Bacillus anthracis sepsis$480,700
U19 · FY2021 · AI · contact PI
Integrative single cell and spatial transcriptomics of salivary glands in Sjogren's syndrome$134,748
R21 · FY2021 · DE · contact PI
Specificity and Molecular Definition of Pathogenic Lymphocytes in Sjogren's Syndrome$540,620
R01 · FY2020 · AR · contact PI
Immune cell mechanisms of Bacillus anthracis sepsis$482,388
U19 · FY2020 · AI · contact PI
Integrative single cell and spatial transcriptomics of salivary glands in Sjogren's syndrome$353,248
R21 · FY2020 · DE · contact PI
Specificity and Molecular Definition of Pathogenic Lymphocytes in Sjogren's Syndrome$534,514
R01 · FY2019 · AR · contact PI
Immune cell mechanisms of Bacillus anthracis sepsis$480,700
U19 · FY2019 · AI · contact PI
Humoral Mechanisms of Protection from Bacillus anthracis Sepsis$688,318
U19 · FY2018 · AI · contact PI
Specificity and Molecular Definition of Pathogenic Lymphocytes in Sjogren's Syndrome$538,519
R01 · FY2018 · AR · contact PI
Humoral Mechanisms of Protection from Bacillus anthracis Sepsis$670,250
U19 · FY2017 · AI · contact PI
Humoral Mechanisms of Protection from Bacillus anthracis Sepsis$591,210
U19 · FY2016 · AI · contact PI
Humoral Mechanisms of Protection from Bacillus anthracis Sepsis$667,536
U19 · FY2015 · AI · contact PI
Novel Approach to T Cell Specificity in Sjogren's Syndrome$374,229
P50 · FY2015 · AR · contact PI
Humoral Mechanisms of Protection from Bacillus anthracis Sepsis$475,872
U19 · FY2014 · AI · contact PI
Novel Approach to T Cell Specificity in Sjogren's Syndrome$376,413
P50 · FY2014 · AR · contact PI
Novel Approach to T Cell Specificity in Sjogren's Syndrome$359,570
P50 · FY2013 · AR · contact PI
Educational Component$55,998
U19 · FY2013 · AI · contact PI
Novel Approach to T Cell Specificity in Sjogren's Syndrome$397,414
P50 · FY2012 · AR · contact PI
T Cell Tolerance & Autoimmunity to Nuclear Antigen La$282,398
R01 · FY2012 · AI · contact PI
Educational Component$58,671
U19 · FY2012 · AI · contact PI
Novel Approach to T Cell Specificity in Sjogren's Syndrome$418,241
P50 · FY2011 · AR · contact PI
T Cell Tolerance & Autoimmunity to Nuclear Antigen La$282,398
R01 · FY2011 · AI · contact PI
Educational Component$109,884
U19 · FY2011 · AI · contact PI
T Cell Tolerance & Autoimmunity to Nuclear Antigen La$285,250
R01 · FY2010 · AI · contact PI
Educational Component$115,760
U19 · FY2010 · AI · contact PI
T Cell Tolerance & Autoimmunity to Nuclear Antigen La$278,250
R01 · FY2009 · AI · contact PI
Do estrogen receptors in B cells and DC mediate sex bias in murine lupus?$238,500
R21 · FY2009 · AI
Educational Component$118,438
U19 · FY2009 · AI · contact PI
Do estrogen receptors in B cells and DC mediate sex bias in murine lupus?$198,750
R21 · FY2008 · AI
Tolerance to the Nuclear Antigen La$106,515
K02 · FY2006 · AI · contact PI
T cell to tolerance &autoimmunity to nuclear antigen La$240,000
R01 · FY2005 · AI
Tolerance to the Nuclear Antigen La$103,221
K02 · FY2005 · AI
Can Somatic Mutations Mediate Anti-La Autoimmunity$258,720
R01 · FY2004 · GM
T cell to tolerance &autoimmunity to nuclear antigen La$240,000
R01 · FY2004 · AI
Tolerance to the Nuclear Antigen La$94,910
K02 · FY2004 · AI
Can Somatic Mutations Mediate Anti-La Autoimmunity$258,720
R01 · FY2003 · GM
T cell to tolerance &autoimmunity to nuclear antigen La$240,000
R01 · FY2003 · AI
Tolerance to the Nuclear Antigen La$93,296
K02 · FY2003 · AI
Can Somatic Mutations Mediate Anti-La Autoimmunity$258,720
R01 · FY2002 · GM
T cell to tolerance &autoimmunity to nuclear antigen La$240,000
R01 · FY2002 · AI
Tolerance to the Nuclear Antigen La$85,899
K02 · FY2002 · AI
B CELL TOLERANCE TO NUCLEAR ANTIGEN LA$0
P50 · FY2002 · AR
T cell to tolerance &autoimmunity to nuclear antigen La$228,000
R01 · FY2001 · AI